Neurotransmitters and microglial-mediated neuroinflammation

Current Protein and Peptide Science

Volumn 14, Issue 1, 2013, Pages 21-32

  Lee, Moonhee ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Acetylcholine; Adrenaline; ATP; GABA; Glutamate; Microglia

Indexed keywords

4 AMINOBUTYRIC ACID RECEPTOR; ADENOSINE RECEPTOR; ADENOSINE TRIPHOSPHATE; ADRENERGIC RECEPTOR; AMPA RECEPTOR; CHOLINERGIC RECEPTOR; CYCLIC AMP; DOPAMINE RECEPTOR; G PROTEIN COUPLED RECEPTOR; INDUCIBLE NITRIC OXIDE SYNTHASE; INTERLEUKIN 6; KAINIC ACID RECEPTOR; MESSENGER RNA; METABOTROPIC RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROTRANSMITTER; PURINERGIC P2X7 RECEPTOR; PURINERGIC P2Y RECEPTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CALCIUM CONDUCTANCE; CELL INTERACTION; CELL PHAGOCYTOSIS; CELL PROLIFERATION; CHEMOTAXIS; CYCLIC AMP RESPONSIVE ELEMENT; DISEASE COURSE; HUMAN; IMMUNOREACTIVITY; MEMBRANE TRANSPORT; MICROGLIA; NERVE STIMULATION; NERVOUS SYSTEM INFLAMMATION; NEUROPATHIC PAIN; NEUROPROTECTION; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

ANIMALS; BRAIN; CHEMOKINES; HUMANS; MICROGLIA; NEURITIS; NEURODEGENERATIVE DISEASES; NEUROTRANSMITTER AGENTS; RECEPTORS, NEUROTRANSMITTER; SYNAPTIC TRANSMISSION;

EID: 84876741388     PISSN: 13892037     EISSN: 18755550     Source Type: Journal    
DOI: 10.2174/1389203711314010005     Document Type: Article

References (155)

1. Nimmerjahn, A.; Kirchhoff, F.; Helmchen, F. Resting microglial cells are highly dynamic surveillants of brain parenchyma in vivo. Science, 2005, 308(5726), 1314-1318.
2. Kettenmann, H.; Hanisch, U.K.; Noda, M.; Verkhratsky, A. Physiology of microglia. Physiol. Rev., 2011, 91(2), 461-553.
3. McGeer, P.L.; Kawamata, T.; Walker, D.G.; Akiyama, H.; Tooyama, I.; McGeer, E.G. Microglia in degenerative neurological disease. GLIA, 1993, 7(1), 84-92.
4. McGeer, P.L.; Rogers, J.; McGeer, E.G. Inflammation, antiinflammatory agents and Alzheimer disease: the last 12 years. J. Alzheimers Dis., 2006, 9(3 Suppl), 271-276.
5. McGeer, P.L.; McGeer, E.G. Glial reactions in Parkinson's disease. Mov. Disord., 2008, 23(4), 474-483.
6. Kelly, R.B.; Deutsch, J.W.; Carlson, S.S.; Wagner, J.A. Biochemistry of neurotransmitter release. Annu. Rev. Neurosci., 1979, 2, 399-446.
7. Eccles, J.C. The synapse: from electrical to chemical transmission. Annu. Rev. Neurosci., 1982, 5, 325-339.
8. Burnstock, G. Historical review: ATP as a neurotransmitter. Trends Pharmacol. Sci., 2006, 27, 166-176.
9. Burnstock, G. Purinergic signalling: an overview. Novartis Found Symp., 2006, 276, 26-57.
10. Burnstock, G.; Fredholm, B.B.; North, R.A.; Verkhratsky, A. The birth and postnatal development of purinergic signalling. Acta Physiol, 2010, 199, 93-147.
11. Burnstock, G.; Verkhratsky, A. Evolutionary origins of the purinergic signalling system. Acta Physiol, 2009, 195, 415-447.
12. Burnstock, G.; Verkhratsky, A. Long-term (trophic) purinergic signalling: purinoceptors control cell proliferation, differentiation and death. Cell Death Dis., 2010, 1, e9.
13. Abbracchio, M.P.; Burnstock, G.; Verkhratsky, A.; Zimmermann, H. Purinergic signalling in the nervous system: an overview. Trends Neurosci., 2009, 32, 19-29.
14. Pankratov, Y.; Lalo, U.; Verkhratsky, A.; North, R.A. Quantal release of ATP in mouse cortex. J. Gen. Physiol., 2007, 129, 257-265.
15. Pankratov, Y.; Lalo, U.; Verkhratsky, A.; North, R.A. Vesicular release of ATP at central synapses. Pflügers Arch., 2006, 452, 589-597.
16. Sperlagh, B.; Illes, P. Purinergic modulation of microglial cell activation. Purinergic Signal, 2007, 3, 117-127.
17. Zhang, Z.; Chen, G.; Zhou, W.; Song, A.; Xu, T.; Luo, Q.; Wang, W.; Gu, X.S.; Duan, S. Regulated ATP release from astrocytes through lysosome exocytosis. Nat Cell Biol., 2007, 9, 945-953.
18. Ryu, J.K.; Kim, J.; Choi, S.H.; Oh, Y.J.; Lee, Y.B.; Kim, S.U.; Jin, B.K. ATP-induced in vivo neurotoxicity in the rat striatum via P2 receptors. Neuroreport, 2002, 13, 1611-1615.
19. Zimmermann, H. Ectonucleotidases in the nervous system. Novartis Found Symp., 2006, 276, 113-130.
20. Burnstock, G. Purine and pyrimidine receptors. Cell Mol. Life Sci., 2007, 64, 1471-1483.
21. Fredholm, B.B.; IJ, A.P.; Jacobson, K.A.; Klotz, K.N.; Linden, J. International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol. Rev., 2001, 53, 527-552.
22. North, R.A. Molecular physiology of P2X receptors. Physiol. Rev., 2002, 82, 1013-1067.
23. Surprenant, A., North, R.A. Signaling at purinergic P2X receptors. Annu. Rev. Physiol., 2009, 71, 333-359, 2009.
24. Fields, R.D.; Burnstock, G. Purinergic signalling in neuron-glia interactions. Nat. Rev. Neurosci., 2006, 7, 423-436.
25. Kirischuk, S.; Moller, T.; Voitenko, N.; Kettenmann, H.; Verkhratsky, A. ATP-induced cytoplasmic calcium mobilization in Bergmann glial cells. J. Neurosci., 1995, 15, 7861-7871.
26. Kirischuk, S.; Scherer, J.; Kettenmann, H.; Verkhratsky, A. Activation of P2-purinoreceptors triggered Ca2+ release from InsP3-sensitive internal stores in mammalian oligodendrocytes. J. Physiol., 1995, 483, 41-57.
27. 5 subunits form the functional P2X receptor in mouse cortical astrocytes. J. Neurosci., 2008, 28, 5473-5480.
28. Verkhratsky, A.; Krishtal, O.A.; Burnstock, G. Purinoceptors on neuroglia. Mol. Neurobiol., 2009, 39, 190-208.
29. 2A signaling. Prog. Neurobiol., 2007, 83, 263-276.
30. 2a-receptors. GLIA, 1996, 18, 152-160.
31. Gebicke-Haerter, P.J.; Christoffel, F.; Timmer, J.; Northoff, H.; Berger, M.; Van Calker, D. Both adenosine A1-and A2-receptors are required to stimulate microglial proliferation. Neurochem. Int., 1996, 29, 37-42.
32. Saura, J.; Angulo, E.; Ejarque, A.; Casado, V.; Tusell, J.M.; Moratalla, R.; Chen, J.F.; Schwarzschild, M.A.; Lluis, C.; Franco, R.; Serratosa, J. Adenosine A2A receptor stimulation potentiates nitric oxide release by activated microglia. J. Neurochem., 2005, 95, 919-929.
33. 2A receptor mediates microglial process retraction. Nat. Neurosci., 2009, 12, 872-878.
34. Stiles, G. L. Adenosine receptors. J. Biol. Chem., 1992, 267(10), 6451-6454.
35. Kalda, A.; Yu, L.; Oztas, E.; Chen, J.F. Novel neuroprotection by caffeine and adenosine A(2A) receptor antagonists in animal models of Parkinson's disease. J. Neurol. Sci., 2006, 248(1-2), 9-15.
36. Hracskó, Z.; Baranyi, M.; Csölle, C.; Gölöncsér, F.; Madarász, E.; Kittel, A.; Sperlágh, B. Lack of neuroprotection in the absence of P2X7 receptors in toxin-induced animal models of Parkinson's disease. Mol. Neurodegener., 2011, 6, 28.
37. Loram, L.C.; Harrison, J.A.; Sloane, E.M.; Hutchinson, M.R.; Sholar, P.; Taylor, F.R.; Berkelhammer, D.; Coats, B.D.; Poole, S.; Milligan, E.D.; Maier, S.F.; Rieger, J.; Watkins, L.R. Enduring reversal of neuropathic pain by a single intrathecal injection of adenosine 2A receptor agonists: a novel therapy for neuropathic pain. J. Neurosci., 2009, 29, 14015-14025.
38. Synowitz, M.; Glass, R.; Farber, K.; Markovic, D.; Kronenberg, G.; Herrmann, K.; Schnermann, J.; Nolte, C.; van Rooijen, N.; Kiwit, J.; Kettenmann, H. A1 adenosine receptors in microglia control glioblastoma-host interaction. Cancer Res., 2006, 66, 8550-8557.
39. Haselkorn, M.L.; Shellington, D.; Jackson, E.; Vagni, V.A.; Janesko, K.L.; Dubey, R.K.; Gillespie, D.G.; Cheng, D.; Bell, M.J.; Jenkins, L.W.; Homanics, G.E.; Schnermann, J.; Kochanek, P.M. Adenosine A1 receptor activation as a brake on the microglial response after experimental traumatic brain injury in mice. J. Neurotrauma., 2010, 27, 901-910.
40. Surprenant, A.; Rassendren, F.; Kawashima, E.; North, R.A.; Buell, G. The cytolytic P2Z receptor for extracellular ATP identified as a P2X receptor (P2X7). Science, 1996, 272, 735-738.
41. North, R.A.; Surprenant, A. Pharmacology of cloned P2X receptors. Annu. Rev. Pharmacol. Toxicol., 2000, 40, 563-580.
42. Burnstock, G.; Knight, G.E. Cellular distribution and functions of P2 receptor subtypes in different systems. Int. Rev. Cytol., 2004, 240, 31-304.
43. Chen, L.; Brosnan, C.F. Regulation of immune response by P2X7 receptor. Crit. Rev. Immunol., 2006, 26, 499-513.
44. Ferrari, D.; Villalba, M.; Chiozzi, P.; Falzoni, S.; Ricciardi-Castagnoli, P.; Di Virgilio, F. Mouse microglial cells express a plasma membrane pore gated by extracellular ATP. J. Immunol., 1996, 156, 1531-1539.
45. Haas, S.; Brockhaus, J.; Verkhratsky, A.; Kettenmann, H. ATPinduced membrane currents in ameboid microglia acutely isolated from mouse brain slices. Neuroscience, 1996, 75, 257-261.
46. Melani, A.; Amadio, S.; Gianfriddo, M.; Vannucchi, M.G.; Volonte, C.; Bernardi, G.; Pedata, F.; Sancesario, G. P2X7 receptor modulation on microglial cells and reduction of brain infarct caused by middle cerebral artery occlusion in rat. J. Cereb. Blood Flow Metab., 2006, 26, 974-982.
47. Yiangou, Y.; Facer, P.; Durrenberger, P.; Chessell, I.P.; Naylor, A.; Bountra, C.; Banati, R.R.; Anand, P. COX-2, CB2 and P2X7-immunoreactivities are increased in activated microglial cells/macrophages of multiple sclerosis and amyotrophic lateral sclerosis spinal cord. BMC Neurol., 2006, 6, 12.
48. Takenouchi, T.; Sekiyama, K.; Sekigawa, A.; Fujita, M.; Waragai, M.; Sugama, S.; Iwamaru, Y.; Kitani, H.; Hashimoto, M. P2X7 receptor signaling pathway as a therapeutic target for neurodegenerative diseases. Arch. Immunol. Ther. Exp., 2010, 58, 91-96.
49. 7 receptor in Alzheimer disease and amyloid-beta peptide-treated microglia and in peptide-injected rat hippocampus. J. Neuropathol. Exp. Neurol., 2006, 65, 1090-1097.
50. 7 mediates superoxide production in primary microglia and is up-regulated in a transgenic mouse model of Alzheimer's disease. J. Biol. Chem., 2003, 278, 13309-13317.
51. Rappold, P.M.; Lynd-Balta, E.; Joseph, S.A. P2X7 receptor immunoreactive profile confined to resting and activated microglia in the epileptic brain. Brain Res., 2006, 1089, 171-178.
52. Choi, H.B.; Ryu, J.K.; Kim, S.U.; McLarnon JG. Modulation of the purinergic P2X7 receptor attenuates lipopolysaccharide-mediated microglial activation and neuronal damage in inflamed brain. J. Neurosci., 2007, 27, 4957-4968.
53. Faria, R.X.; Defarias, F. P.; Alves, L. A. Are second messengers crucial for opening the pore associated with P2X7 receptor? Am. J. Physiol. Cell Physiol., 2005, 288(2), C260-C271.
54. Mattson, M. P. Calcium and neurodegeneration. Aging Cell, 2007, 6(3), 337-350.
55. Lee, M.; Jantaratnotai, N.; McGeer, E.; McLarnon, J.G.; McGeer, P.L. Mg2+ ions reduce microglial and THP-1 cell neurotoxicity by inhibiting Ca2+ entry through purinergic channels. Brain Res., 2011, 1369, 21-35.
56. 7 receptor: a key player in IL-1 processing and release. J. Immunol., 2006, 176, 3877-3883.
57. Pelegrin, P.; Surprenant, A. Pannexin-1 mediates large pore formation and interleukin-1β release by the ATP-gated P2X7 receptor. EMBO J., 2006, 25, 5071-5082.
58. 7 receptors on microglial cells mediate injury to cortical neurons in vitro. GLIA, 2006, 54, 234-242.
59. Bernardino, L.; Balosso, S.; Ravizza, T.; Marchi, N.; Ku, G.; Randle, J.C.; Malva, J.O.; Vezzani, A. Inflammatory events in hippocampal slice cultures prime neuronal susceptibility to excitotoxic injury: a crucial role of P2X7 receptor-mediated IL-1 release. J. Neurochem., 2008, 106, 271-280.
60. 7 nucleotide receptor activation enhances IFN γ-induced type II nitric oxide synthase activity in BV-2 microglial cells. J. Neurochem., 2003, 87, 344-352.
61. Rampe, D.; Wang, L.; Ringheim, G.E. P2X7 receptor modulation of β-amyloid-and LPS-induced cytokine secretion from human macrophages and microglia. J. Neuroimmunol., 2004, 147, 56-61.
62. Ferrari, D.; Chiozzi, P.; Falzoni, S.; Hanau, S.; Di Virgilio, F. Purinergic modulation of interleukin-1 β release from microglial cells stimulated with bacterial endotoxin. J. Exp. Med., 1997, 185, 579-582.
63. Woolf, C.J.; Mannion, R.J. Neuropathic pain: aetiology, symptoms, mechanisms, and management. Lancet, 1999, 353, 1959-1964.
64. Eriksson, N.P.; Persson, J.K.; Svensson, M.; Arvidsson, J.; Molander, C.; Aldskogius, H. A quantitative analysis of the microglial cell reaction in central primary sensory projection territories following peripheral nerve injury in the adult rat. Exp. Brain Res., 1993, 96, 19-27.
65. Svensson, M.; Eriksson, P.; Persson, J.K.; Molander, C.; Arvidsson, J.; Aldskogius, H. The response of central glia to peripheral nerve injury. Brain Res. Bull., 1993, 30, 499-506.
66. Gehrmann, J.; Banati, R.B. Microglial turnover in the injured CNS: activated microglia undergo delayed DNA fragmentation following peripheral nerve injury. J. Neuropathol. Exp. Neurol., 1995, 54, 680-688.
67. Narita, M.; Yoshida, T.; Nakajima, M.; Miyatake, M.; Takagi, T.; Yajima, Y.; Suzuki, T. Direct evidence for spinal cord microglia in the development of a neuropathic pain-like state in mice. J. Neurochem., 2006, 97: 1337-1348.
68. Coyle, D.E. Partial peripheral nerve injury leads to activation of astroglia and microglia which parallels the development of allodynic behavior. GLIA, 1998, 23, 75-83.
69. Inoue, K. ATP receptors of microglia involved in pain. Novartis Found Symp., 2006, 276, 263-281.
70. Inoue, K. The function of microglia through purinergic receptors: neuropathic pain and cytokine release. Pharmacol. Ther., 2006, 109, 210-226.
71. Inoue, K. Purinergic systems in microglia. Cell Mol. Life Sci., 2008, 65, 3074-3080.
72. Inoue, K.; Tsuda, M.; Koizumi, S. Chronic pain and microglia: the role of ATP. Novartis Found Symp., 2004, 261, 55-64.
73. Trang, T.; Beggs, S.; Salter, M.W. Purinoceptors in microglia and neuropathic pain. Pflügers Arch., 2006, 452, 645-652.
74. Tsuda, M.; Shigemoto-Mogami, Y; Koizumi, S; Mizokoshi, A; Kohsaka, S; Salter, M.W.; Inoue, K. P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury. Nature, 2003, 424, 778-783.
75. Guo, L.H.; Schluesener, H.J. Acute but not chronic stimulation of glial cells in rat spinal cord by systemic injection of lipopolysaccharide is associated with hyperalgesia. Acta. Neuropathol., 2006, 112, 703-713.
76. Stokes, L.; Surprenant, A. Dynamic regulation of the P2X4 receptor in alveolar macrophages by phagocytosis and classical activation. Eur. J. Immunol., 2009, 39, 986-995.
77. 7 receptor complexes in rodent immune cells. J. Biol. Chem., 2009, 284, 13446-13454.
78. Inoue, K., Tsuda, M., Tozaki-Saitoh, H. Modification of neuropathic pain sensation through microglial ATP receptors. Purinergic Signal, 1007, 3, 311-316.
79. Tsuda, M.; Inoue, K.; Salter, M.W. Neuropathic pain and spinal microglia: a big problem from molecules in "small" glia. Trends Neurosci., 2005, 28, 101-107.
80. Gong, Q.J.; Li, Y.Y.; Xin, W.J.; Zang, Y.; Ren, W.J.; Wei, X.H.; Zhang, T.; Liu, X.G. ATP induces long-term potentiation of Cfiber-evoked field potentials in spinal dorsal horn: the roles of P2X4 receptors and p38 MAPK in microglia. GLIA, 2009, 57, 583-591.
81. Coull, J.A.; Beggs, S.; Boudreau, D.; Boivin, D.; Tsuda, M.; Inoue, K.; Gravel, C.; Salter, M.W.; De Koninck, Y. BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain. Nature, 2005, 438, 1017-1021.
82. 4 receptors in spinal microglia after peripheral nerve injury mediates BDNF release and neuropathic pain. J. Neurosci., 2008, 28, 11263-11268.
83. Fischer, W.; Krugel, U. P2Y receptors: focus on structural, pharmacological and functional aspects in the brain. Curr. Med. Chem., 2007, 14, 2429-2455.
84. Abbracchio, M.P.; Burnstock, G.; Boeynaems, J.M.; Barnard, E.A.; Boyer, J.L.; Kennedy, C.; Knight, G.E.; Fumagalli, M.; Gachet, C.; Jacobson, K.A.; Weisman, G.A. International Union of Pharmacology LVIII: update on the P2Y G protein-coupled nucleotide receptors: from molecular mechanisms and pathophysiology to therapy. Pharmacol. Rev., 2006, 58, 281-341.
85. Light, A.R.; Wu, Y.; Hughen, R.W.; Guthrie, P.B. Purinergic receptors activating rapid intracellular Ca increases in microglia. Neuron. Glia Biol., 2006, 2, 125-138.
86. McLarnon, J.G. Purinergic mediated changes in Ca2+ mobilization and functional responses in microglia: effects of low levels of ATP. J. Neurosci. Res., 2005, 81, 349-356.
87. 2+ signals are induced by low compared with high concentrations of P2Y agonists in microglia. Purinergic Signal, 2006, 2, 605-617.
88. Koizumi, S.; Shigemoto-Mogami, Y.; Nasu-Tada, K.; Shinozaki, Y.; Ohsawa, K.; Tsuda, M.; Joshi, B.V.; Jacobson, K.A.; Kohsaka, S.; Inoue, K. UDP acting at P2Y6 receptors is a mediator of microglial phagocytosis. Nature, 2007, 446, 1091-1095.
89. Honda, S.; Sasaki, Y.; Ohsawa, K.; Imai, Y.; Nakamura, Y.; Inoue, K.; Kohsaka, S. Extracellular ATP or ADP induce chemotaxis of cultured microglia through Gi/o-coupled P2Y receptors. J. Neurosci., 2001, 21, 1975-1982.
90. Haynes, S.E.; Hollopeter, G.; Yang, G.; Kurpius, D.; Dailey, M.E.; Gan, W.B.; Julius, D. The P2Y12 receptor regulates microglial activation by extracellular nucleotides. Nat. Neurosci., 2006, 9, 1512-1519.
91. Irino, Y.; Nakamura, Y.; Inoue, K.; Kohsaka, S.; Ohsawa, K. Akt activation is involved in P2Y12 receptor-mediated chemotaxis of microglia. J. Neurosci. Res., 2008, 86, 1511-1519.
92. Ohsawa, K.; Irino, Y.; Nakamura, Y.; Akazawa, C.; Inoue, K.; Kohsaka, S. Involvement of P2X4 and P2Y12 receptors in ATPinduced microglial chemotaxis. GLIA, 2007, 55, 604-616.
93. Inoue, K.; Tsuda, M. Microglia and neuropathic pain. GLIA, 2009, 57, 1469-1479.
94. 12 receptor upregulation in activated microglia is a gateway of p38 signaling and neuropathic pain. J. Neurosci., 2008, 28, 2892-2902.
95. Tozaki-Saitoh, H.; Tsuda, M.; Miyata, H.; Ueda, K.; Kohsaka, S.; Inoue, K. P2Y12 receptors in spinal microglia are required for neuropathic pain after peripheral nerve injury. J. Neurosci., 2008, 28, 4949-4956.
96. Noda, M.; Nakanishi, H.; Nabekura, J.; Akaike, N. AMPA-kainate subtypes of glutamate receptor in rat cerebral microglia. J. Neurosci., 2000, 20, 251-258.
97. Hagino, Y.; Kariura, Y.; Manago, Y.; Amano, T.; Wang, B.; Sekiguchi, M.; Nishikawa, K.; Aoki, S.; Wada, K.; Noda, M. Heterogeneity and potentiation of AMPA type of glutamate receptors in rat cultured microglia. GLIA, 2004, 47, 68-77.
98. Eun, S.Y.; Hong, Y.H.; Kim, E.H.; Jeon, H.; Suh, Y.H.; Lee, J.E.; Jo, C.; Jo, S.A.; Kim, J. Glutamate receptor-mediated regulation of c-fos expression in cultured microglia. Biochem. Biophys. Res. Commun., 2004, 325, 320-327.
99. Liu, G.J.; Nagarajah, R.; Banati, R.B.; Bennett, M.R. Glutamate induces directed chemotaxis of microglia. Eur. J. Neurosci., 2009, 29, 1108-1118.
100. Christensen, R.N.; Ha, B.K.; Sun, F.; Bresnahan, J.C.; Beattie, M.S. Kainate induces rapid redistribution of the actin cytoskeleton in ameboid microglia. J. Neurosci. Res., 2006, 84, 170-181.
101. Zhu, W.; Zheng, H.; Shao, X.; Wang, W.; Yao, Q.; Li, Z. Excitotoxicity of TNFα derived from KA activated microglia on hippocampal neurons in vitro and in vivo. J. Neurochem., 2010, 114, 386-396.
102. Hirayama, M.; Kuriyama, M. MK-801 is cytotoxic to microglia in vitro and its cytotoxicity is attenuated by glutamate, other excitotoxic agents and atropine. Possible presence of glutamate receptor and muscarinic receptor on microglia. Brain Res., 2001, 897, 204-206.
103. Thomas, D.M.; Kuhn, D.M. MK-801 and dextromethorphan block microglial activation and protect against methamphetamineinduced neurotoxicity. Brain Res., 2005, 1050, 190-198.
104. Streit, W.J.; Morioka, T.; Kalehua, A.N. MK-801 prevents microglial reaction in rat hippocampus after forebrain ischemia. Neuroreport, 1992, 3, 146-148.
105. Conn, P.J.; Pin, J.P. Pharmacology and functions of metabotropic glutamate receptors. Annu. Rev. Pharmacol. Toxicol., 1997, 37, 205-237.
106. Endoh, T. Characterization of modulatory effects of postsynaptic metabotropic glutamate receptors on calcium currents in rat nucleus tractus solitarius. Brain Res., 2004, 1024(1-2), 212-224.
107. Bonsi, P.; Cuomo, D.; De Persis, C.; Centonze, D.; Bernardi, G.; Calabresi, P.; Pisani, A. Modulatory action of metabotropic glutamate receptor (mGluR) 5 on mGluR1 function in striatal cholinergic interneurons. Neuropharmacology, 2005, 49(Suppl 1), 104-113.
108. Hinoi, E.; Ogita, K.; Takeuchi, Y.; Ohashi, H.; Maruyama, T.; Yoneda Y. Characterization with [3H]quisqualate of group I metabotropic glutamate receptor subtype in rat central and peripheral excitable tissues. Neurochem. Int., 2001, 38(3): 277-285.
109. Biber, K.; Laurie, D.J.; Berthele, A.; Sommer, B.; Tolle, T.R.; Gebicke-Harter, P.J.; van Calker, D.; Boddeke, H.W. Expression and signaling of group I metabotropic glutamate receptors in astrocytes and microglia. J. Neurochem., 1999, 72, 1671-1680.
110. Farso, M.C.; O'Shea, R.D.; Beart, P.M. Evidence group I mGluR drugs modulate the activation profile of lipopolysaccharideexposed microglia in culture. Neurochem. Res., 2009, 34, 1721-1728.
111. Taylor, D.L.; Diemel, L.T.; Pocock, J.M. Activation of microglial group III metabotropic glutamate receptors protects neurons against microglial neurotoxicity. J. Neurosci., 2003, 23, 2150-2160.
112. Kaushal, V.; Schlichter, L.C. Mechanisms of microglia-mediated neurotoxicity in a new model of the stroke penumbra. J. Neurosci., 2008, 28, 2221-2230.
113. Taylor, D.L.; Diemel, L.T.; Cuzner, M.L.; Pocock, J.M. Activation of group II metabotropic glutamate receptors underlies microglial reactivity and neurotoxicity following stimulation with chromogranin A, a peptide up-regulated in Alzheimer's disease. J. Neurochem., 2002, 82, 1179-1191.
114. Lee, M.; Schwab, C.; McGeer, P.L. Astrocytes are GABAergic cells that modulate microglial activity. GLIA, 2011, 59(1), 152-165.
115. Lee, M.; McGeer, E.G.; McGeer, P.L. Mechanisms of GABA release from human astrocytes. GLIA, 2011, 59(11), 1600-1611.
116. B receptors to modulate interleukin release. Mol. Cell Neurosci., 2004, 25(2), 312-322.
117. Carnevale, D.; De Simone, R.; Minghetti, L.; Microglia-neuron interaction in inflammatory and degenerative diseases: role of cholinergic and noradrenergic systems. CNS Neurol. Disord. Drug Targets, 2007, 6, 388-397.
118. Wang, H.; Yu, M.; Ochani, M.; Amella, C.A.; Tanovic, M.; Susarla, S.; Li, J.H.; Yang, H.; Ulloa, L.; Al-Abed, Y.; Czura, C.J.; Tracey, K.J. Nicotinic acetylcholine receptor α7 subunit is an essential regulator of inflammation. Nature, 2003, 421, 384-388.
119. Weber, M.; Motin, L.; Gaul, S.; Beker, F.; Fink, R. H,; Adams, D. J. Intravenous anaesthetics inhibit nicotinic acetylcholine receptormediated currents and Ca2+ transients in rat intracardiac ganglion neurons. Br. J. Pharmacol., 2005, 144 (1), 98-107.
120. Beker, F.; Weber, M.; Fink, R.H.; Adams, D. J. Muscarinic and nicotinic ACh receptor activation differentially mobilize Ca2+ in rat intracardiac ganglion neurons. J. Neurophysiol., 2003, 90(3), 1956-1964.
121. Pitchford, S.; Day, J.W.; Gordon, A.; Mochly-Rosen, D. Nicotinic acetylcholine receptor desensitisation is regulated by activationinduced extracellular adenosine accumulation. J. Neurosci., 1992, 12(11), 4540-4544.
122. Safran, A.; Sagi-Eisenberg, R.; Neumann, D.; Fuchs, S. Phosphorylation of the acetylcholine receptor by protein kinase C and identification of the phosphorylation site within the receptor delta subunit. J Biol. Chem., 1987, 262(22), 10506-10510.
123. De Simone, R.; Ajmone-Cat, M.A.; Carnevale, D.; Minghetti, L. Activation of α7 nicotinic acetylcholine receptor by nicotine selectively up-regulates cyclooxygenase-2 and prostaglandin E2 in rat microglial cultures. J. Neuroinflamm., 2005, 2, 4.
124. Shytle, R.D.; Mori, T.; Townsend, K.; Vendrame, M.; Sun, N.; Zeng, J.; Ehrhart, J.; Silver, A.A.; Sanberg, P.R.; Tan, J. Cholinergic modulation of microglial activation by 7 nicotinic receptors. J. Neurochem., 2004, 89, 337-343.
125. Rock, R.B.; Gekker, G.; Aravalli, R.N.; Hu, S.; Sheng, W.S.; Peterson, P.K. Potentiation of HIV-1 expression in microglial cells by nicotine: involvement of transforming growth factor-β 1. J. Neuroimmune Pharmacol., 2008, 3, 143-149.
126. 3 pathway and modulate the cell activation toward a neuroprotective role. J. Neurosci. Res., 2006, 83, 1461-1470.
127. Whittemore, E.R.; Korotzer, A.R.; Etebari, A.; Cotman, C.W. Carbachol increases intracellular free calcium in cultured rat microglia. Brain Res., 1993, 621, 59-64.
128. Zhang, L.; McLarnon, J.G.; Goghari, V.; Lee, Y.B.; Kim, S.U.; Krieger, C. Cholinergic agonists increase intracellular Ca2+ in cultured human microglia. Neurosci. Lett., 1998, 255, 33-36.
129. 1-42-stimulated microglia. Exp. Mol. Med., 2008, 40, 11-18.
130. Ohnishi, M.; Katsuki, H.; Takagi, M.; Kume, T.; Akaike, A. Longterm treatment with nicotine suppresses neurotoxicity of, microglial activation by, thrombin in cortico-striatal slice cultures. Eur. J. Pharmacol., 2009, 602, 288-293.
131. Giunta, B.; Ehrhart, J.; Townsend, K.; Sun, N.; Vendrame, M.; Shytle, D.; Tan, J.; Fernandez, F. Galantamine and nicotine have a synergistic effect on inhibition of microglial activation induced by HIV-1 gp120. Brain Res. Bull., 2004, 64, 165-170.
132. Hwang, J.; Hwang, H.; Lee, H.W.; Suk, K. Microglia signaling as a target of donepezil. Neuropharmacology, 2010, 58(7), 1122-1129.
133. Brenner, T.; Nizri, E.; Irony-Tur-Sinai, M.; Hamra-Amitay, Y.; Wirguin, I. Acetylcholinesterase inhibitors and cholinergic modulation in Myasthenia Gravis and neuroinflammation. J. Neuroimmunol., 2008, 201-202, 121-127.
134. Prinz, M.; Hausler, K.G.; Kettenmann, H.; Hanisch, U. β-Adrenergic receptor stimulation selectively inhibits IL-12p40 release in microglia. Brain Res., 2001, 899, 264-270.
135. Tanaka, K.F.; Kashima, H.; Suzuki, H.; Ono, K.; Sawada, M. Existence of functional β1-and β2-adrenergic receptors on microglia. J. Neurosci. Res., 2002, 70, 232-237.
136. Mori, K.; Ozaki, E.; Zhang, B.; Yang, L.; Yokoyama, A.; Takeda, I.; Maeda, N.; Sakanaka, M.; Tanaka, J. Effects of norepinephrine on rat cultured microglial cells that express α1, α2, β1 and β2 adrenergic receptors. Neuropharmacology, 2002, 43, 1026-1034.
137. Hetier, E.; Ayala, J.; Bousseau, A. Prochiantz, A. Modulation of interleukin-1 and tumor necrosis factor expression by betaadrenergic agonists in mouse ameboid microglial cells. Exp Brain Res., 1991, 86, 407-413.
138. Tomozawa, Y.; Yabuuchi, K.; Inoue, T.; Satoh, M. Participation of cAMP and cAMP-dependent protein kinase in betaadrenoceptormediated interleukin-1 beta mRNA induction in cultured microglia. Neurosci. Res., 1995, 22, 399-409.
139. Farber, K.; Pannasch, U.; Kettenmann, H. Dopamine and noradrenaline control distinct functions in rodent microglial cells. Mol. Cell Neurosci., 2005, 29, 128-138.
140. Fujita, H.; Tanaka, J.; Maeda, N.; Sakanaka, M. Adrenergic agonists suppress the proliferation of microglia through β 2-adrenergic receptor. Neurosci. Lett., 1998, 242, 37-40.
141. Morioka, N.; Tanabe, H.; Inoue, A.; Dohi, T.; Nakata, Y. Noradrenaline reduces the ATP-stimulated phosphorylation of p38 MAP kinase via beta-adrenergic receptors-cAMP-protein kinase Adependent mechanism in cultured rat spinal microglia. Neurochem. Int., 2009, 55, 226-234.
142. Heneka, M.T.; Nadrigny, F.; Regen, T.; Martinez-Hernandez, A.; Dumitrescu-Ozimek, L.; Terwel, D.; Jardanhazi-Kurutz, D.; Walter, J.; Kirchhoff, F.; Hanisch, U.K.; Kummer, M.P. Locus ceruleus controls Alzheimer's disease pathology by modulating microglial functions through norepinephrine. Proc. Natl. Acad. Sci. USA., 2010, 107, 6058-6063.
143. Wang, J.; Li, J.; Sheng, X.; Zhao, H.; Cao, X.D.; Wang, Y.Q.; Wu, G.C. β-Adrenoceptor mediated surgery-induced production of proinflammatory cytokines in rat microglia cells. J. Neuroimmunol., 2010, 223, 77-83.
144. Qian, L.; Hu, X.; Zhang, D.; Snyder, A.; Wu, H.M.; Li, Y.; Wilson, B.; Lu, R.B.; Hong, J.S.; Flood, P.M. β2 Adrenergic receptor activation induces microglial NADPH oxidase activation and dopaminergic neurotoxicity through an ERK-dependent/protein kinase A-independent pathway. GLIA, 2009, 57, 1600-1609.
145. Spano, P. F.; Govoni, S.; Tra-bucchi, M. Studies on the pharmacological properties of dopamine receptors invarious areas of the central nervous system. Adv. Biochem. Psychopharmacol., 1978, 19, 155-165.
146. Kebabian, J. W.; Calne, D. B. Multiple receptors for dopamine. Nature, 1979, 277, 93-96.
147. Beaulieu, J. M.; Del'Guidice, T.; Sotnikova, T. D.; Lemasson, M.; Gainetdinov, R. R. Beyond cAMP: The Regulation of Akt and GSK3 by Dopamine Receptors. Front Mol. Neurosci., 2011, 4, 38.
148. Mastroeni, D.; Grover, A.; Leonard, B.; Joyce, J.N.; Coleman, P.D.; Kozik, B.; Bellinger, D.L.; Rogers, J. Microglial responses to dopamine in a cell culture model of Parkinson's disease. Neurobiol. Aging, 2009, 30, 1805-1817.
149. Lawson, L.J.; Perry, V.H.; Dri, P.; Gordon, S. Heterogeneity in the distribution and morphology of microglia in the normal adult mouse brain. Neuroscience, 1990, 39, 151-170.
150. Rogers, J.; Mastroeni, D.; Leonard, B.; Joyce, J.; Grover, A. Neuroinflammation in Alzheimer's disease and Parkinson's disease: are microglia pathogenic in either disorder? Int. Rev. Neurobiol., 2007, 82, 235-246.
151. Beaulieu, J. M.; Gainetdinov, R. R. The physiology, signaling, and pharmacology of dopamine receptors. Pharmacol. Rev., 2011, 63(1), 182-217.
152. Lee, S. P.; So, C.H.; Rashid, A.J.; Varghese, G.; Cheng, R.; Lanca, A. J.; O'Dowd, B. F.; George, S. R. Dopamine D1 and D2 receptor Co-activation generates a novel phospholipase C-mediated calcium signal. J. Biol. Chem., 2004, 279, 35671-35678.
153. Nishi, A.; Snyder, G.L.; Greengard, P. Bidirectional regulation of DARPP-32 phosphorylation by dopamine. J. Neurosci., 1997, 17, 8147-8155.
154. Missale, C.; Nash, S. R.; Robinson, S.W.; Jaber, M.; Caron, M. G. Dopamine receptors: from structure to function. Physiol. Rev., 1998, 78, 189-225.
155. Tanaka, K.; Okada, Y.; Kanno, T.; Otomo, A.; Yanagisawa, Y.; Shouguchi-Miyata, J.; Suga, E.; Kohiki, E.; Onoe, K.; Osuga, H.; Aoki, M.; Hadano, S.; Itoyama, Y.; Ikeda, J.E. A dopamine receptor antagonist L-745,870 suppresses microglia activation in spinal cord and mitigates the progression in ALS model mice. Exp. Neurol., 2008, 211, 378-386.